tallózása szerző szerint "Ozaltin F"

A találatok rendezése: Rendezés: Találatok:

  • Lipska BS; Ranchin B; Iatropoulos P; Gellermann J; Melk A; Ozaltin F; Caridi G; Seeman T; Tory, Kálmán; Jankauskiene A; Zurowska A; Szczepanska M; Wasilewska A; Harambat J; Trautmann A; Peco-Antic A; Borzecka H; Moczulska A; Saeed B; Bogdanovic R; Kalyoncu M; Simkova E; Erdogan O; Vrljicak K; Teixeira A; Azocar M; Schaefer F; PodoNet Consortium (2014)
    WT1 mutations cause a wide spectrum of renal and extrarenal manifestations. Here we evaluated disease prevalence, phenotype spectrum, and genotype-phenotype correlations of 61 patients with WT1-related steroid-resistant ...
  • Shroff R; Aitkenhead H; Costa N; Trivelli A; Litwin M; Picca S; Anarat A; Sallay, Péter; Ozaltin F; Zurowska A; Jankauskiene A; Montini G; Charbit M; Schaefer F; Wuhl E; ESCAPE Trial Group (2016)
    Angiotensin-converting enzyme inhibitors (ACEi) for renin-angiotensin-aldosterone system (RAAS) blockade are routinely used to slow CKD progression. However, vitamin D may also promote renoprotection by suppressing renin ...